Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation

Akpanova, D.; Berkinbayev, S.; Ospanova, D.; Musagaliyeva, A.

dc.contributor.author	Akpanova, D.
dc.contributor.author	Berkinbayev, S.
dc.contributor.author	Ospanova, D.
dc.contributor.author	Musagaliyeva, A.
dc.date.accessioned	2017-09-19T11:23:31Z
dc.date.available	2017-09-19T11:23:31Z
dc.date.issued	2017-09-15
dc.identifier.citation	Akpanova, D. et al.(2017) Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation. National Laboratory Astana, Nazarbayev University	ru_RU
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/2621
dc.language.iso	en	ru_RU
dc.publisher	National Laboratory Astana, Nazarbayev University	ru_RU
dc.rights	Open Access - the content is available to the general public	ru_RU
dc.rights	Attribution-NonCommercial-ShareAlike 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/us/	*
dc.subject	atrial fibrillation	ru_RU
dc.subject	warfarin	ru_RU
dc.subject	gene polymorphism	ru_RU
dc.title	Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation	ru_RU
dc.type	Abstract	ru_RU